Almost everyone is infected with one or several of the following viruses:

• Human Papilloma Virus (HPV)

• Epstein-Barr Virus (EBV)

• Herpes Simplex Virus (HSV)

• Hepatitis Virus (Hepatitis C Virus, HCV, Hepatitis B Virus, HBV, etc.)

• Cytomegalovirus (CMV)

You can take a blood test and discover the viruses that reside in your body.

When it comes to latent viruses, it’s all about numbers. When the immune system is strong, the number of latent viruses in the body is low, and the person is healthy. When the immune system is weak, the number of latent viruses goes up, and the risk of developing a disease also goes up.

What decreases the efficiency of the immune system?

1. Aging. The efficiency of the immune system declines with aging.

2. Medications, especially, long term, such as medications for lowering cholesterol, or lowering blood pressure. Medications can hurt the immune system, especially, those taken for months or even years.

3. Surgery, chemotherapy. Surgery and chemotherapy put enormous pressure on the immune system.

4. Radiation, such as X-Ray radiation, sunlight, or cell phone radiation. Radiation is known to change the efficiency of the immune system.

5. Stress. Extensive research shows that excessive stress damages the immune system.

How can one target latent viruses?

First, it is important to remember that an infection with a latent virus is not a disease. See the following quotes from the NIH website:

“The terms “infection” and “disease” are not synonymous. An infection results when a pathogen invades and begins growing within a host. Disease results only if and when, as a consequence of the invasion and growth of a pathogen, tissue function is impaired.”

Source: http://science.education.nih.gov/supplements/nih1/Diseases/guide/understanding1.htm

“Acute viral infection associated with active replication and production of virions (presence of disease) is very different from the persistent, latent and asymptomatic type of specific virus-host relationship (absence of disease). In the latter case the virus genome is maintained in the host but no virions are produced for long periods of time and no antiviral host immune response is elicited. Small amounts of virions are produced episodically which is sufficient for transmission of the virus to new hosts. Host switching involves changing over from an absence of disease in the latent host to the reappearance of disease by reactivation in a different type of host. This is the event that sometimes gives rise to an emergent viral disease.”

Source: http://www.niaid.nih.gov/topics/viral/Documents/newepi_program.pdf

However, if you want to help your immune system target the latent viruses in your body, take Gene-Eden-VIR.

Why did polyDNA, the developer of Gene-Eden-VIR, choose to target latent viruses?

polyDNA is interested in latent viruses because of Dr. Hanan Polansky’s (PhD) theory. His theory explains how the genetic material of the most common latent viruses can cause many major diseases without damaging (mutating) the human DNA. Dr. Polansky published the theory in his highly acclaimed purple book titled Microcompetition with Foreign DNA and the Origin of Chronic Disease. The book has been read by more than 5,000 scientists around the world, and has been reviewed in more than 20 leading scientific journals (see here).

Some of these reviews were written by the following scientists (click on the name to read the review):

Professor Marc Pouliot, Department of Anatomy and Physiology, Faculty of Medicine, University of Laval, Canada
Professor Elena N. Naumova, Professor of Public Health and Family Medicine, Director of the NIH-sponsored Tufts Imitative for Forecasting and Modeling of Infectious Diseases, Department of Family Medicine and Community Health, Tufts University School of Medicine
Professor John A. Pickrell, Environmental Toxicology, Kansas State University College of Veterinary Medicine
Professor (Yurek) Jerzy K. Kulski, Division of Molecular Life Science, Department of Genetic Information, Tokai University School of Medicine, Japan and Associate Professor, Centre for Bioinformatics and Biological Computing, Murdoch University, Australia
Professor Raxit J. Jariwalla, Laboratory of Viral, Immune and Malignant Diseases, California Institute for Medical Research
Professor Yvonne R. Thorstenson, Stanford Genome Technology Center, Stanford University

In addition, many major universities invited Dr. Polansky to present his discovery in seminars and workshops, including Stanford University, the University of California in San Francisco, and Rochester University. Dr. Polansky was also invited to present his discovery in several universities and the Health Ministry in Israel.

Central Virology Laboratory, Chaim Sheba Medical Center, Tel-Hashomer, Ramat Gan – Host: Professor Ella Mendelson, PhD, Director of the Laboratory
Department of Virology, Hebrew University, Hadassah Medical Center, Ein Karem, Jerusalem – Host: Professor Amos Panet, PhD, Department Head
Sharett Institute of Oncology, Hadassah University Hospital, Ein Karem, Jerusalem – Host: Professor Tamar Peretz-Yablonski, Head of Institute
Cancer Research Center, Chaim Sheba Medical Center, Tel Hashomer, Ramat Gan – Host Professor Gideon Rechavi, Head of the Center

Also, in 2008, patent offices around the world, including the Australian Patent Office, the Israeli Patent Office, and the United States Patent Office, possibly the patent office with the highest standard of proof in the world, examined the science in Dr. Polansky’s studies and decided to grant him a patent based on his scientific work.

Finally, Dr. Hanan Polansky’s scientific work has been repeatedly reported on television, radio, newspapers and magazines.